Finance Minister Nirmala Sitharaman’s forthcoming budget to be presented in parliament on February 1 is a much-expected one, particularly by the Indian healthcare and pharmaceutical industry. Sharing the recommendations industry experts inform that the 2024-25 for the lifescience sector expect the budget to accelerate innovation and R&D, increase in healthcare spending to 2.5 per cent of GDP and rationalisation of the framework.
